TNON — Tenon Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $6.53m
- -$0.00m
- $3.28m
- 21
- 39
- 15
- 14
Annual cashflow statement for Tenon Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.705 | -7.08 | -18.9 | -15.6 | -13.7 |
| Depreciation | |||||
| Non-Cash Items | 0.184 | 2.22 | 4.88 | 4.14 | 3.89 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.354 | 0.452 | 1.72 | -1.17 | -0.746 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.167 | -4.29 | -12 | -12.2 | -9.88 |
| Capital Expenditures | — | -0.102 | -0.847 | -0.361 | -0.186 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -4.4 | -2.04 | 6.5 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | -4.5 | -2.88 | 6.14 | -0.186 |
| Financing Cash Flow Items | -0.052 | -0.357 | -0.025 | -0.509 | -1.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.255 | 11.5 | 14.1 | 6.3 | 14.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.094 | 2.67 | -0.788 | 0.299 | 4.11 |